HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients

BACKGROUND: Overexpression of human epidermal growth factor receptor type 2 (HER2) occurs in almost 25-30% of androgen receptor (AR)-positive salivary gland carcinomas (SGCs), notably salivary duct carcinoma (SDC) and adenocarcinoma not otherwise specified (NOS). In the last years, several studies h...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalieri, Stefano, Nuzzolese, Imperia, Ottini, Arianna, Bergamini, Cristiana, Resteghini, Carlo, Colombo, Elena, Alfieri, Salvatore, Quattrone, Pasquale, Calareso, Giuseppina, Iacovelli, Nicola Alessandro, Franceschini, Marzia, Licitra, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887140/
https://www.ncbi.nlm.nih.gov/pubmed/36733354
http://dx.doi.org/10.3389/fonc.2022.1096068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887140/
https://www.ncbi.nlm.nih.gov/pubmed/36733354
http://dx.doi.org/10.3389/fonc.2022.1096068

Ejemplares similares